Funding · Company
OrsoBio, Inc.
Palo Alto, CABiotech & Pharma
OrsoBio, Inc. of Palo Alto, CA has disclosed $125M across 2 Form D offerings filed with the SEC between Nov 13, 2023 and Aug 28, 2024.
$125M
Total disclosed
2
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$40M
Form D · Aug 28, 2024 ↗
Q3 2024
· target $67M
Filing details
HeadquartersPalo Alto, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0002000354Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →